You appear to be offline. Some data may be unavailable until your connection is restored.

LH

Stock

Laboratory Corp Of America Holdings

Create price alert
$372.32
+$0.09 (0.02%)
At close: Nov 12, 2026, 4:00 PM

Description

Laboratory Corp. of America Holdings (Labcorp) operates as a health‑care services company that provides clinical laboratory testing and drug‑development support through two primary segments: Diagnostics, which offers a broad menu of routine, specialty, genetic and genomic tests to physicians, hospitals, health plans, employers and consumers via a network of roughly 2,000 patient‑service centers and digital platforms; and Biopharma Laboratory Services, which delivers central‑lab, bioanalytical and companion‑diagnostic services for pharmaceutical and biotechnology companies during clinical trials. The firm is classified in the health‑care sector, specifically within clinical laboratory diagnostics and life‑science services. Labcorp is one of the nation’s two largest independent clinical laboratories, holding roughly a fifth of the independent lab market and supporting a high proportion of FDA‑approved drugs through its testing capabilities, making it a prominent player in both patient diagnostics and biopharma research.

Quarterly Earnings

QuarterDateEPS
Q4 FY26Jan 26, 2027 (est.)—
Q3 FY26Oct 28, 2026$4.78
Q2 FY26Jul 30, 2026$4.99
Q1 FY26Apr 30, 2026$4.25
Q4 FY25Feb 17, 2026$4.07

Stay ahead of LH earnings

Get reminders ahead of LH's next earnings report, so you always know when results are coming.

Other Healthcare stocks in the S&P 500